Table 2 Duration of interferon treatment and reason for stopping treatment

From: Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study

  Number of patients Median (range) time (in months) on interferon
All patients 144 5 (<1–88)
Interferon stopped   
 Disease progression 61 8 (1–66)
 Toxicity 50 3 (<1–37)
 Patient desire 14 7 (<1–48)
 Other 8 38 (1–71)
 Death of patient 4 8 (3–14)
 Not stated 4 22 (7–51)
Treatment status unknown at last review 3 54 (51–88)